Clinical trials
Parkinson clinical trials
Below are recruiting parkinson clinical trials, each written for real people, not researchers. We’re tracking 735 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03523104Recruiting
Registry for Parkinson’s with LRRK2 gene variants
This study is a registry that collects information from people with Parkinson’s who have specific LRRK2 gene changes. It helps researchers understand how this genetic form of Parkinson’s behaves over time.
Changsha, HunanAges Any age - NCT03523052Recruiting
People with Parkinson’s and SNCA gene changes
This registry study enrolls people who have Parkinson’s disease and carry certain SNCA gene changes. It aims to better understand how these genetic changes relate to Parkinson’s, which can guide future research and care.
Changsha, HunanAges Any age - NCT03523065Recruiting
Parkinson’s registry for people with GBA gene changes
This registry collects information about people with Parkinson’s who have specific changes in the GBA gene. The goal is to better understand how these gene changes affect Parkinson’s and support future research.
Changsha, HunanAges Any age - NCT03495024RecruitingPhase 4
Varenicline for quitting smoking in people with schizophrenia
This trial tests whether varenicline helps people with schizophrenia or schizoaffective disorder stop smoking. It also looks at related nervous-system side effects that can happen with some anti-psychotic medicines.
Philadelphia, PennsylvaniaAges 18–75 - NCT03992625Recruiting
Deep brain stimulation study for Parkinson’s, tremor, or dystonia
This trial studies outcomes after deep brain stimulation (a treatment that uses implanted electrodes) for people with Parkinson’s disease, essential tremor, or dystonia. It may help doctors understand who benefits most and how outcomes change after treatment.
St Louis, MissouriAges Any age - NCT03887663Recruiting
Chinese Parkinson’s disease patient registry
This study is a registry that collects information from people with Parkinson’s disease to better understand the condition. You may help researchers learn about patterns of symptoms and care over time.
Changzhi, HunanAges Any age - NCT05493514Recruiting
Robotic training program for walking and balance
This trial studies whether a robotic training system (called G-EO) can help people with neurological conditions improve walking and balance. It may help by testing which factors predict who benefits most, and it requires regular training sessions.
MilanAges 18 years+ - NCT03217396Recruiting
Study blood and MRI markers in people with multiple sclerosis
This study looks for signs of “synapse damage” in multiple sclerosis using blood tests and brain imaging (MRI). The goal is to find biomarkers that may help better understand MS and how it changes over time.
Pozzilli, IserniaAges 18–65 - NCT05767151Recruiting
Newly diagnosed Parkinson’s study for early disease
This study looks at people newly diagnosed with Parkinson’s disease, before starting Parkinson’s medicines, to better understand early illness. It may help researchers identify patterns that could guide future treatments.
Changsha, HunanAges 30–75 - NCT04844060Recruiting
Study collecting spinal fluid from patients needing a lumbar puncture
This study collects cerebrospinal fluid (the fluid around the brain and spinal cord) during a lumbar puncture. It aims to improve how doctors use this information for accurate diagnosis in patients who need the procedure.
StrasbourgAges Any age - NCT06062693Recruiting
Home Hand Training with Sensors for Better Dexterity
This study tests a new home-based hand training system using sensors to help improve hand movement and dexterity in people with Parkinson's, multiple sclerosis, or stroke. It also includes healthy volunteers for comparison.
LucerneAges 18–99 - NCT03371407Recruiting
Study brain movement training in people with Parkinson’s
This study looks at how people with Parkinson’s adapt their movements and how their brain sensorimotor system works. It may help researchers improve understanding of Parkinson’s and refine movement-focused therapies.
MarseilleAges 18 years+ - NCT07863180RecruitingPhase 1/Phase 2
Tributyrin for progressive supranuclear palsy
This trial tests a supplement called tributyrin to see if it can help people with progressive supranuclear palsy (PSP), a condition that affects movement and balance. The study is done virtually, so you can participate from home with a caregiver's help.
Ann Arbor, MichiganAges 45 years+ - NCT07868614Recruiting
Comparing brain signal recordings during deep brain stimulation surgery
This study compares a new device for recording brain signals during deep brain stimulation (DBS) surgery with the standard equipment. DBS is a treatment for movement disorders like Parkinson's disease that uses a device to send electrical signals to specific parts of the brain.
Rochester, MinnesotaAges 18 years+ - NCT07859020Recruiting
AI-assisted diagnosis of fast heart rhythms from ECG
This study uses artificial intelligence to analyze ECG recordings and help identify the exact type and location of fast heart rhythms (tachycardia). It may improve the accuracy and speed of diagnosis for conditions like supraventricular tachycardia, Wolff-Parkinson-White syndrome, premature ventricular contractions, and ventricular tachycardia.
Incheon, IncheonAges 19 years+ - NCT07846007Recruiting
Ultrasound brain stimulation for Parkinson's disease
This study tests a non-invasive ultrasound treatment that gently stimulates a small part of the brain to see if it can improve Parkinson's symptoms like movement and stiffness. It may be an option for people who have not had brain surgery yet.
Toronto, OntarioAges 18–90 - NCT07850674Recruiting
Spinal stiffness and fear of movement in Parkinson's
This study looks at how Parkinson's disease affects neck and back movement, stiffness, and fear of movement, in relation to jaw joint problems. The results may help improve therapies that target flexibility and quality of life.
HatayAges 35–75 - NCT07840508Recruiting
High-speed strength training for Parkinson's disease
This study tests a special exercise program that focuses on moving quickly to improve strength and movement in people with Parkinson's disease. It may help with walking and daily activities.
Coral Gables, FloridaAges 50–85 - NCT07835308RecruitingEarly Phase 1
Smart tuning of brain stimulation for better walking
This study is testing a new way to adjust deep brain stimulation (DBS) settings to improve walking in people with Parkinson's disease. If you have DBS and can walk with stimulation off, this trial may help fine-tune your treatment to improve your gait.
Minneapolis, MinnesotaAges 18 years+ - NCT04114994Recruiting
Memory testing study for adults 50 and older
This study checks how people’s thinking and memory change over time using a specific cognitive test. It may help researchers understand patterns of memory change and supports future research on brain health.
Miami, FloridaAges 50 years+ - NCT07777484RecruitingPhase 1
Study of TRB-001 vaccine for Parkinson's disease after prior immunotherapy
This study tests an experimental vaccine called TRB-001 in people with Parkinson's disease who have already received a previous immunotherapy targeting alpha-synuclein. The goal is to see if the vaccine is safe and how it affects the immune system and the disease.
ViennaAges 18 years+ - NCT06505460Recruiting
Brain stimulation for Parkinson's freezing of gait
This study is testing if two brain-stimulation treatments—deep brain stimulation (DBS) or focused ultrasound—can help reduce freezing of gait (a common, frustrating symptom where your feet feel stuck when walking) in people with Parkinson's. Researchers will use brain scans and electrical recordings to understand how these treatments work.
TaichungAges 20–90 - NCT07745673Recruiting
Study of targeted treatment for Parkinson's disease symptoms
This study compares different ways of targeting treatment for Parkinson's disease symptoms. It is designed for people with mild to moderate Parkinson's who have had symptoms for at least 2 years and are generally stable on their current medications.
Wuhan, HubeiAges 40 years+ - NCT06608875Recruiting
Personalized stimulation to improve walking and balance
This trial tests a way to help people with Parkinson's disease improve their walking and balance by using personalized stimulation. If you have trouble with walking or balance and are already planning rehab at cereneo, you might be able to join.
Zurich, Canton of ZurichAges 18 years+
Hear when a new Parkinson trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for parkinson?
- Yes. Clin2 currently lists 735 recruiting parkinson studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a parkinson trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a parkinson trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.